Reported outcomes of children with newly diagnosed high-grade gliomas treated with nimotuzumab and irinotecan
Crossref DOI link: https://doi.org/10.1007/s00381-017-3409-y
Published Online: 2017-04-24
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sirachainan, Nongnuch
Boongird, Atthaporn
Swangsilpa, Thiti
Klaisuban, Wipawi
Lusawat, Apasri
Hongeng, Suradej
Funding for this research was provided by:
Cancer Research Center, Faculty of Medicine, Ramathibodi Hospital
License valid from 2017-04-24